open access

Vol 66, No 3 (2015)
Postgraduate education
Published online: 2015-07-01
Submitted: 2015-03-30
Accepted: 2015-04-08
Get Citation

Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs)

Aleksandra Rutkowska, Dominik Rachoń, Andrzej Milewicz, Marek Ruchała, Marek Bolanowski, Diana Jędrzejuk, Tomasz Bednarczuk, Maria Górska, Alicja Hubalewska-Dydejczyk, Beata Kos- Kudła, Andrzej Lewiński, Wojciech Zgliczyński
DOI: 10.5603/EP.2015.0035
·
Endokrynologia Polska 2015;66(3):276-285.

open access

Vol 66, No 3 (2015)
Postgraduate education
Published online: 2015-07-01
Submitted: 2015-03-30
Accepted: 2015-04-08

Abstract

With the reference to the position statements of the Endocrine Society, the Paediatric Endocrine Society, and the European Society of Paediatric Endocrinology, the Polish Society of Endocrinology points out the adverse health effects caused by endocrine disrupting chemicals (EDCs) commonly used in daily life as components of plastics, food containers, pharmaceuticals, and cosmetics. The statement is based on the alarming data about the increase of the prevalence of many endocrine disorders such as: cryptorchidism, precocious puberty in girls and boys, and hormone-dependent cancers (endometrium, breast, prostate). In our opinion, it is of human benefit to conduct epidemiological studies that will enable the estimation of the risk factors of exposure to EDCs and the probability of endocrine disorders. Increasing consumerism and the industrial boom has led to severe pollution of the environment with a corresponding negative impact on human health; thus, there is great necessity for the biomonitoring of EDCs in Poland. (Endokrynol Pol 2015; 66 (3): 276–285)

Abstract

With the reference to the position statements of the Endocrine Society, the Paediatric Endocrine Society, and the European Society of Paediatric Endocrinology, the Polish Society of Endocrinology points out the adverse health effects caused by endocrine disrupting chemicals (EDCs) commonly used in daily life as components of plastics, food containers, pharmaceuticals, and cosmetics. The statement is based on the alarming data about the increase of the prevalence of many endocrine disorders such as: cryptorchidism, precocious puberty in girls and boys, and hormone-dependent cancers (endometrium, breast, prostate). In our opinion, it is of human benefit to conduct epidemiological studies that will enable the estimation of the risk factors of exposure to EDCs and the probability of endocrine disorders. Increasing consumerism and the industrial boom has led to severe pollution of the environment with a corresponding negative impact on human health; thus, there is great necessity for the biomonitoring of EDCs in Poland. (Endokrynol Pol 2015; 66 (3): 276–285)

Get Citation

Keywords

endocrine disrupting chemicals; EDC; bisphenol; BPA; phthalate

About this article
Title

Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs)

Journal

Endokrynologia Polska

Issue

Vol 66, No 3 (2015)

Pages

276-285

Published online

2015-07-01

DOI

10.5603/EP.2015.0035

Bibliographic record

Endokrynologia Polska 2015;66(3):276-285.

Keywords

endocrine disrupting chemicals
EDC
bisphenol
BPA
phthalate

Authors

Aleksandra Rutkowska
Dominik Rachoń
Andrzej Milewicz
Marek Ruchała
Marek Bolanowski
Diana Jędrzejuk
Tomasz Bednarczuk
Maria Górska
Alicja Hubalewska-Dydejczyk
Beata Kos- Kudła
Andrzej Lewiński
Wojciech Zgliczyński

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl